Your browser doesn't support javascript.
loading
Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
Raman, Ruchir; Ramamohan, Varun; Rathore, Anurag; Jain, Deepali; Mohan, Anant; Vashistha, Vishal.
Afiliação
  • Raman R; Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Delhi, India.
  • Ramamohan V; Department of Chemical Engineering, Indian Institute of Technology, Delhi, India.
  • Rathore A; Department of Mechanical Engineering, Indian Institute of Technology, Delhi, India.
  • Jain D; Centre of Excellence for Biopharmaceutical Technology, Indian Institute of Technology, Delhi, India.
  • Mohan A; Department of Chemical Engineering, Indian Institute of Technology, Delhi, India.
  • Vashistha V; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Asia Pac J Clin Oncol ; 19(1): 158-171, 2023 Feb.
Article em En | MEDLINE | ID: mdl-35634796

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article